DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Syrma SGS Technology Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 8:33 am

Syrma SGS Technology

Syrma SGS Technology has received a compliance certificate from the stock exchanges. This document confirms that the company has fulfilled all its obligations under SEBI's Depositories and Participants Regulations for the quarter ended September 30, 2026. It is a standard administrative requirement for listed entities to maintain transparency with their shareholders and regulators.

For investors, this news is largely procedural. It indicates that the company is in good standing with market authorities and has met its regulatory deadlines. It does not reflect any specific financial performance or operational change, but rather serves as a routine confirmation of corporate governance compliance.

Investors should treat this as a routine update. There are no immediate market-moving implications, but keeping an eye on the company's future quarterly filings remains important for tracking its overall regulatory compliance and corporate health.